Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Daclizumab 16.D.4 Adverse Effects of Immunosuppressant Medications 16.D.6
Dantrium 54.C.9 54.C.6
Dantrolene 54.A.2 54.B.4 54.C.5 54.C.8 54.D.1 54.A.12 54.B.2 54.B.5 54.C.6 54.C.9 54.D.2
Dapsone
DDAVP 16.B.6 31.B.10 31.B.8 Von Willebrand Disease: Diagnosis, Classification, and Response to Desmopressin D-Arginine Vasopressin (DDAVP) 13.A.5 31.A.6 31.B.11 57.C.20
Demerol
Desmopressin 16.B.6 31.B.10 31.B.8 Von Willebrand Disease: Diagnosis, Classification, and Response to Desmopressin D-Arginine Vasopressin (DDAVP) 13.A.5 31.A.6 31.B.11 57.C.20
Dexmedetomidine
Dextromethorphan
Dextrose in water 5.C.II-14 Drug Treatment for Hyperkalemia 19.C.5 Cardiac Anesthesia Intravenous Medications Osmotic Values of Common Intravenous Fluids
Dextrose
Diazepam 16.C.3 25.B.3 34.C.8 58.D.7 11.B.7 24.C.15 28.B.6 48.C.3
Dibucaine 55.A.5 Relation Between Dibucaine Number and Duration of Succinylcholine Neuromuscular Blockade 55.A.6
Diclofenac 51.C.5 2.D.2 63.B.5
Didanosine
Diethylstilbestrol
Digoxin 29.A.19 43.B.7 61.B.4 13.E.6 29.C.9 44.A.8 62.C.1
Demecarium
Dexamethasone
Dextran
Dibenzyline
Dideoxyinosine
Dilaudid 51.A.11 Routes of Opioid Administration 51.A.8
Dimenhydrinate Choices of Antiemetic Agents in Adults: Dosage and Timing Flow Chart for Management of PONV in the Context of Enhanced Recovery
Dinoprostone 27.C.6 44.A.9 43.A.9 50.A.6
Dihydroxyaluminum sodium carbonate
Diltiazem
Diphenhydramine 24.A.2 25.B.3 Common Medications in the Perioperative Period with Potential Neurological Effects 1.C.12 24.D.5 4.B.2
Dipyridamole 10.B.2 16.B.1 14.B.4 51.A.13
Dobutamine 10.B.2 12.C.6 14.B.4 37.C.2 7.C.11 Cardiac Anesthesia Intravenous Medications 12.B.2 13.D.3 16.B.1 43.B.7 7.C.9

NDX